Vidan Diagnostics Announces the Availability of Glucose Test for Lucidplus™

SAN ANTONIO, TX – September 6, 2018 – Vidan Diagnostics, LLC, is pleased to announce the availability of its glucose test for the Lucidplus™ B-Ketone plus Glucose Monitoring System.

Originally launching its first product in the U.S. market with a focus on ketone testing, Vidan Diagnostics has received tremendous interest in the glucose application of its product.

The Lucidplus™ Glucose test is a CLIA waived, whole blood test that features an extended range of 10 to 800 mg/dL to capture extreme glucose levels, a hematocrit range of 20 to 70% to minimize interference of low or high hematocrit levels, as well as, high accuracy of its results that correlate to serum glucose
testing run in the central laboratory. “These three features alone make the Lucidplus™ Glucose test a best-in-class test over other available products in the United States” says Al Blanco, COO of Vidan Diagnostics, LLC. “In speaking with lab directors, the ability to test for elevated glucose levels and reflex to a β-ketone test all on the same device puts the Lucidplus™ System in a league of its own.”

Additional features of the Lucidplus™ Monitoring System include individually wrapped test strips to maximize shelf-life, storage of up to 1,000 test results, small sample volume, quick results, strip ejection function and sleek design.

Vidan Diagnostics LLC is a supplier of medical diagnostic products. It is focused on medical devices and reagents used for diagnosing and monitoring patients with conditions of diabetes, sepsis, anemia, heart disease and stroke. Vidan Diagnostics is dedicated to delivering proven and innovative products to all people in all places, in all aspects and stages of life with integrity and reliability. The company is headquartered in San Antonio, Texas.